Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pulmonary Disease, Chronic Obstructive | 106 | 2024 | 3204 | 8.600 |
Why?
|
Pulmonary Emphysema | 57 | 2024 | 684 | 7.250 |
Why?
|
Tomography, X-Ray Computed | 131 | 2024 | 20570 | 4.630 |
Why?
|
Lung | 90 | 2024 | 10000 | 3.930 |
Why?
|
Lung Diseases, Interstitial | 27 | 2024 | 918 | 2.650 |
Why?
|
Smoking | 55 | 2024 | 9053 | 2.480 |
Why?
|
Pulmonary Artery | 18 | 2024 | 1927 | 2.220 |
Why?
|
Respiratory Function Tests | 36 | 2021 | 1682 | 2.090 |
Why?
|
Emphysema | 15 | 2024 | 238 | 2.030 |
Why?
|
Airway Remodeling | 10 | 2016 | 133 | 1.970 |
Why?
|
Forced Expiratory Volume | 45 | 2024 | 1814 | 1.960 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 14 | 2019 | 1222 | 1.430 |
Why?
|
Pneumonectomy | 9 | 2015 | 1119 | 1.330 |
Why?
|
Pectoralis Muscles | 4 | 2024 | 85 | 1.300 |
Why?
|
Thorax | 6 | 2023 | 555 | 1.260 |
Why?
|
Spirometry | 21 | 2024 | 929 | 1.180 |
Why?
|
Radiography, Thoracic | 9 | 2017 | 1302 | 1.050 |
Why?
|
Bronchography | 4 | 2013 | 75 | 0.990 |
Why?
|
Lung Diseases | 9 | 2022 | 1909 | 0.970 |
Why?
|
Pulmonary Veins | 7 | 2021 | 743 | 0.930 |
Why?
|
Bronchiectasis | 6 | 2022 | 139 | 0.850 |
Why?
|
Total Lung Capacity | 10 | 2016 | 149 | 0.800 |
Why?
|
Vital Capacity | 19 | 2024 | 971 | 0.780 |
Why?
|
Pattern Recognition, Automated | 6 | 2020 | 997 | 0.760 |
Why?
|
Idiopathic Pulmonary Fibrosis | 5 | 2019 | 515 | 0.760 |
Why?
|
Respiratory Mechanics | 6 | 2013 | 699 | 0.690 |
Why?
|
Pulmonary Heart Disease | 1 | 2019 | 34 | 0.680 |
Why?
|
Middle Aged | 145 | 2024 | 220895 | 0.670 |
Why?
|
Exercise Tolerance | 8 | 2024 | 836 | 0.650 |
Why?
|
Mucin-5B | 7 | 2019 | 148 | 0.630 |
Why?
|
Aged | 122 | 2024 | 169289 | 0.620 |
Why?
|
Male | 166 | 2024 | 360804 | 0.610 |
Why?
|
Lung Diseases, Obstructive | 2 | 2021 | 308 | 0.600 |
Why?
|
Humans | 220 | 2024 | 761504 | 0.580 |
Why?
|
Heart Ventricles | 5 | 2021 | 3807 | 0.580 |
Why?
|
Severity of Illness Index | 40 | 2021 | 15842 | 0.580 |
Why?
|
Female | 167 | 2024 | 392644 | 0.570 |
Why?
|
Bronchi | 5 | 2022 | 845 | 0.570 |
Why?
|
Hypertension, Pulmonary | 8 | 2024 | 1578 | 0.570 |
Why?
|
Dyspnea | 6 | 2015 | 1347 | 0.560 |
Why?
|
Aortic Diseases | 3 | 2012 | 735 | 0.550 |
Why?
|
Lung Injury | 2 | 2019 | 422 | 0.540 |
Why?
|
Wolves | 1 | 2016 | 10 | 0.530 |
Why?
|
Pulmonary Fibrosis | 6 | 2021 | 505 | 0.530 |
Why?
|
Calcinosis | 3 | 2015 | 1469 | 0.480 |
Why?
|
Aortography | 3 | 2015 | 421 | 0.480 |
Why?
|
Bronchiolitis Obliterans | 2 | 2014 | 213 | 0.470 |
Why?
|
Algorithms | 13 | 2020 | 14031 | 0.470 |
Why?
|
Lymphangioleiomyomatosis | 1 | 2016 | 201 | 0.450 |
Why?
|
Cohort Studies | 33 | 2024 | 41487 | 0.450 |
Why?
|
Disease Progression | 21 | 2024 | 13506 | 0.450 |
Why?
|
Proteomics | 2 | 2024 | 3849 | 0.440 |
Why?
|
Longitudinal Studies | 26 | 2024 | 14605 | 0.440 |
Why?
|
Mexican Americans | 1 | 2014 | 167 | 0.420 |
Why?
|
Reproducibility of Results | 22 | 2024 | 20098 | 0.420 |
Why?
|
Ventricular Dysfunction, Right | 4 | 2021 | 628 | 0.420 |
Why?
|
Radiographic Image Enhancement | 6 | 2014 | 876 | 0.420 |
Why?
|
Bronchodilator Agents | 2 | 2014 | 512 | 0.390 |
Why?
|
Preoperative Period | 1 | 2014 | 551 | 0.390 |
Why?
|
Asthma | 7 | 2022 | 6234 | 0.390 |
Why?
|
Organ Size | 7 | 2019 | 2254 | 0.380 |
Why?
|
Airway Obstruction | 5 | 2023 | 661 | 0.380 |
Why?
|
Imaging, Three-Dimensional | 6 | 2019 | 4063 | 0.380 |
Why?
|
Image Processing, Computer-Assisted | 9 | 2019 | 9000 | 0.370 |
Why?
|
Pulmonary Valve | 1 | 2015 | 411 | 0.370 |
Why?
|
Respiratory Physiological Phenomena | 1 | 2012 | 189 | 0.370 |
Why?
|
Pulmonary Ventilation | 2 | 2009 | 372 | 0.360 |
Why?
|
Absorptiometry, Photon | 1 | 2017 | 1738 | 0.360 |
Why?
|
Magnetic Resonance Imaging | 8 | 2018 | 36426 | 0.360 |
Why?
|
Diagnostic Imaging | 4 | 2023 | 3530 | 0.350 |
Why?
|
Densitometry | 1 | 2010 | 151 | 0.340 |
Why?
|
Sensitivity and Specificity | 15 | 2017 | 14666 | 0.340 |
Why?
|
Genetic Predisposition to Disease | 15 | 2019 | 17904 | 0.330 |
Why?
|
alpha 1-Antitrypsin Deficiency | 1 | 2009 | 112 | 0.320 |
Why?
|
Genome-Wide Association Study | 12 | 2020 | 12690 | 0.310 |
Why?
|
Linear Models | 11 | 2019 | 5871 | 0.300 |
Why?
|
Tomography, Optical Coherence | 2 | 2012 | 2917 | 0.300 |
Why?
|
Multivariate Analysis | 15 | 2019 | 12059 | 0.290 |
Why?
|
Regression Analysis | 9 | 2022 | 6343 | 0.280 |
Why?
|
Positron-Emission Tomography | 2 | 2014 | 6485 | 0.270 |
Why?
|
Trachea | 3 | 2013 | 1089 | 0.270 |
Why?
|
Nutrition Surveys | 1 | 2014 | 1733 | 0.270 |
Why?
|
Arteriosclerosis | 1 | 2010 | 1055 | 0.260 |
Why?
|
Mucus | 3 | 2023 | 341 | 0.260 |
Why?
|
Aged, 80 and over | 33 | 2023 | 58976 | 0.260 |
Why?
|
Predictive Value of Tests | 12 | 2020 | 15266 | 0.250 |
Why?
|
Polymorphism, Genetic | 5 | 2017 | 4243 | 0.250 |
Why?
|
Hemodynamics | 2 | 2021 | 4159 | 0.240 |
Why?
|
Genetic Loci | 4 | 2019 | 2632 | 0.240 |
Why?
|
Arthritis, Rheumatoid | 4 | 2024 | 3763 | 0.230 |
Why?
|
Idiopathic Interstitial Pneumonias | 1 | 2024 | 24 | 0.230 |
Why?
|
Aorta, Thoracic | 1 | 2010 | 1096 | 0.230 |
Why?
|
Aorta | 3 | 2019 | 2042 | 0.230 |
Why?
|
Echocardiography | 3 | 2021 | 4989 | 0.220 |
Why?
|
Prognosis | 15 | 2023 | 29625 | 0.220 |
Why?
|
Case-Control Studies | 16 | 2020 | 22176 | 0.220 |
Why?
|
Liver Transplantation | 1 | 2015 | 2330 | 0.210 |
Why?
|
Bronchitis, Chronic | 2 | 2014 | 82 | 0.210 |
Why?
|
Niacin | 1 | 2023 | 118 | 0.210 |
Why?
|
Pulmonary Embolism | 3 | 2021 | 2567 | 0.210 |
Why?
|
Proportional Hazards Models | 11 | 2022 | 12463 | 0.210 |
Why?
|
Residual Volume | 3 | 2011 | 41 | 0.200 |
Why?
|
Adult | 36 | 2024 | 221177 | 0.200 |
Why?
|
Observer Variation | 5 | 2017 | 2606 | 0.200 |
Why?
|
Pulmonary Diffusing Capacity | 3 | 2013 | 94 | 0.200 |
Why?
|
Tobacco Smoke Pollution | 3 | 2019 | 819 | 0.200 |
Why?
|
Azithromycin | 2 | 2014 | 199 | 0.190 |
Why?
|
Posture | 1 | 2005 | 957 | 0.190 |
Why?
|
Molecular Epidemiology | 2 | 2022 | 469 | 0.190 |
Why?
|
Hospitalization | 4 | 2015 | 10723 | 0.190 |
Why?
|
Thrombolytic Therapy | 2 | 2020 | 2064 | 0.180 |
Why?
|
Respiratory System Abnormalities | 1 | 2021 | 67 | 0.180 |
Why?
|
Lung Volume Measurements | 3 | 2013 | 375 | 0.180 |
Why?
|
Schistosomiasis | 1 | 2021 | 65 | 0.180 |
Why?
|
Follow-Up Studies | 18 | 2022 | 39106 | 0.180 |
Why?
|
Phenotype | 14 | 2022 | 16591 | 0.180 |
Why?
|
Respiratory Tract Diseases | 2 | 2018 | 750 | 0.180 |
Why?
|
Blood Vessels | 2 | 2018 | 1113 | 0.170 |
Why?
|
Fibrinolytic Agents | 2 | 2020 | 2084 | 0.170 |
Why?
|
Environmental Exposure | 4 | 2019 | 4486 | 0.170 |
Why?
|
Risk Factors | 23 | 2021 | 74206 | 0.170 |
Why?
|
Polymorphism, Single Nucleotide | 9 | 2019 | 15936 | 0.170 |
Why?
|
Tomography, Emission-Computed | 1 | 2022 | 1122 | 0.170 |
Why?
|
Esophagus | 1 | 2005 | 1033 | 0.170 |
Why?
|
Survival Rate | 7 | 2021 | 12725 | 0.170 |
Why?
|
Exhalation | 3 | 2013 | 181 | 0.170 |
Why?
|
Sex Factors | 7 | 2020 | 10552 | 0.160 |
Why?
|
Logistic Models | 10 | 2019 | 13255 | 0.160 |
Why?
|
Transforming Growth Factor beta2 | 1 | 2019 | 71 | 0.160 |
Why?
|
Risk Assessment | 10 | 2021 | 23995 | 0.160 |
Why?
|
Phlebography | 1 | 2019 | 326 | 0.150 |
Why?
|
Prospective Studies | 19 | 2024 | 54425 | 0.150 |
Why?
|
Prevalence | 13 | 2023 | 15732 | 0.150 |
Why?
|
Tidal Volume | 2 | 2011 | 488 | 0.150 |
Why?
|
Respiratory System | 2 | 2019 | 563 | 0.150 |
Why?
|
Muscular Atrophy | 1 | 2021 | 334 | 0.150 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2014 | 5671 | 0.150 |
Why?
|
Therapy, Computer-Assisted | 1 | 2019 | 266 | 0.150 |
Why?
|
Quality of Life | 9 | 2022 | 13367 | 0.150 |
Why?
|
Bronchoscopy | 2 | 2018 | 909 | 0.140 |
Why?
|
DNA | 3 | 2018 | 7212 | 0.140 |
Why?
|
Retrospective Studies | 19 | 2024 | 80636 | 0.140 |
Why?
|
ROC Curve | 5 | 2024 | 3579 | 0.140 |
Why?
|
Mortality | 2 | 2019 | 2901 | 0.140 |
Why?
|
Pneumococcal Vaccines | 2 | 2012 | 397 | 0.140 |
Why?
|
Particulate Matter | 4 | 2019 | 2605 | 0.140 |
Why?
|
Cardiac Volume | 1 | 2017 | 197 | 0.130 |
Why?
|
Promoter Regions, Genetic | 5 | 2019 | 5789 | 0.130 |
Why?
|
Pleural Diseases | 1 | 2017 | 137 | 0.130 |
Why?
|
Radiation Dosage | 3 | 2019 | 1958 | 0.130 |
Why?
|
Models, Economic | 1 | 2020 | 716 | 0.130 |
Why?
|
Pleura | 1 | 2017 | 245 | 0.130 |
Why?
|
Vasodilation | 1 | 2019 | 962 | 0.130 |
Why?
|
Clothing | 1 | 2016 | 97 | 0.130 |
Why?
|
Statistics as Topic | 3 | 2011 | 2358 | 0.130 |
Why?
|
Tomography, Spiral Computed | 2 | 2014 | 273 | 0.130 |
Why?
|
Asbestos | 1 | 2017 | 251 | 0.120 |
Why?
|
Vasodilator Agents | 1 | 2019 | 973 | 0.120 |
Why?
|
Ventricular Function | 1 | 2017 | 406 | 0.120 |
Why?
|
Autophagy | 2 | 2013 | 1326 | 0.120 |
Why?
|
Postoperative Complications | 2 | 2014 | 15631 | 0.120 |
Why?
|
Iceland | 3 | 2020 | 184 | 0.120 |
Why?
|
Cross-Sectional Studies | 9 | 2022 | 26125 | 0.120 |
Why?
|
Cryopreservation | 1 | 2020 | 728 | 0.120 |
Why?
|
Galectin 3 | 1 | 2016 | 240 | 0.120 |
Why?
|
Solitary Pulmonary Nodule | 1 | 2018 | 278 | 0.120 |
Why?
|
Biological Specimen Banks | 1 | 2020 | 783 | 0.110 |
Why?
|
Acute Disease | 6 | 2024 | 7237 | 0.110 |
Why?
|
Respiratory Muscles | 1 | 2014 | 142 | 0.110 |
Why?
|
Antirheumatic Agents | 1 | 2023 | 1372 | 0.110 |
Why?
|
Endotoxins | 1 | 2016 | 520 | 0.110 |
Why?
|
United States | 16 | 2021 | 72334 | 0.110 |
Why?
|
Muscle Strength | 1 | 2018 | 624 | 0.110 |
Why?
|
Blood Volume | 1 | 2015 | 547 | 0.110 |
Why?
|
Oxygen Consumption | 3 | 2022 | 1866 | 0.110 |
Why?
|
Radiography | 6 | 2016 | 6965 | 0.110 |
Why?
|
Gene Expression Regulation | 4 | 2019 | 11903 | 0.110 |
Why?
|
Sheep | 1 | 2016 | 1440 | 0.110 |
Why?
|
Busulfan | 1 | 2014 | 258 | 0.110 |
Why?
|
Body Mass Index | 7 | 2021 | 12953 | 0.110 |
Why?
|
Nitric Oxide | 2 | 2019 | 2135 | 0.110 |
Why?
|
Seasons | 1 | 2019 | 1520 | 0.100 |
Why?
|
Odds Ratio | 3 | 2021 | 9646 | 0.100 |
Why?
|
Drug Monitoring | 1 | 2018 | 962 | 0.100 |
Why?
|
Exercise Test | 5 | 2022 | 2127 | 0.100 |
Why?
|
Temperature | 1 | 2019 | 2226 | 0.100 |
Why?
|
Young Adult | 7 | 2024 | 59243 | 0.100 |
Why?
|
Artificial Intelligence | 2 | 2022 | 2578 | 0.100 |
Why?
|
Adenocarcinoma | 2 | 2023 | 6346 | 0.100 |
Why?
|
Simvastatin | 1 | 2014 | 346 | 0.100 |
Why?
|
Contrast Media | 3 | 2014 | 5311 | 0.100 |
Why?
|
Pulmonary Circulation | 1 | 2014 | 737 | 0.090 |
Why?
|
Pulmonary Edema | 1 | 2014 | 409 | 0.090 |
Why?
|
Dilatation, Pathologic | 1 | 2012 | 527 | 0.090 |
Why?
|
Phantoms, Imaging | 4 | 2017 | 2526 | 0.090 |
Why?
|
Subcutaneous Fat | 1 | 2014 | 393 | 0.090 |
Why?
|
Fibrinogen | 1 | 2014 | 888 | 0.090 |
Why?
|
Inhalation Exposure | 1 | 2013 | 432 | 0.090 |
Why?
|
Lipoxygenase Inhibitors | 1 | 2011 | 93 | 0.090 |
Why?
|
Bronchioles | 1 | 2010 | 30 | 0.090 |
Why?
|
Population Surveillance | 1 | 2021 | 2598 | 0.090 |
Why?
|
Normal Distribution | 1 | 2011 | 272 | 0.090 |
Why?
|
Cysts | 1 | 2015 | 681 | 0.090 |
Why?
|
Thymus Gland | 1 | 2015 | 1243 | 0.090 |
Why?
|
Chi-Square Distribution | 3 | 2011 | 3416 | 0.090 |
Why?
|
Vehicle Emissions | 1 | 2015 | 656 | 0.090 |
Why?
|
Orthomyxoviridae Infections | 3 | 1997 | 254 | 0.090 |
Why?
|
Leukocytes | 1 | 2018 | 2026 | 0.080 |
Why?
|
Hydroxyurea | 1 | 2011 | 284 | 0.080 |
Why?
|
Body Composition | 2 | 2021 | 2426 | 0.080 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2015 | 1241 | 0.080 |
Why?
|
Cilia | 1 | 2013 | 495 | 0.080 |
Why?
|
Comorbidity | 6 | 2017 | 10508 | 0.080 |
Why?
|
Cause of Death | 2 | 2020 | 3683 | 0.080 |
Why?
|
Biological Products | 1 | 2018 | 914 | 0.080 |
Why?
|
Walking | 3 | 2013 | 1198 | 0.080 |
Why?
|
Age Factors | 8 | 2021 | 18395 | 0.080 |
Why?
|
Toll-Like Receptors | 1 | 2013 | 589 | 0.080 |
Why?
|
Boston | 3 | 2017 | 9326 | 0.080 |
Why?
|
Histone Deacetylases | 1 | 2013 | 719 | 0.080 |
Why?
|
Demography | 1 | 2014 | 1648 | 0.080 |
Why?
|
Research Design | 2 | 2023 | 6180 | 0.080 |
Why?
|
Toll-Like Receptor 4 | 1 | 2012 | 579 | 0.080 |
Why?
|
Fibroblasts | 1 | 2019 | 4141 | 0.080 |
Why?
|
Endothelium, Vascular | 1 | 2021 | 4431 | 0.080 |
Why?
|
Perfusion Imaging | 1 | 2010 | 196 | 0.080 |
Why?
|
Hemagglutinins, Viral | 3 | 1997 | 66 | 0.080 |
Why?
|
Air Pollution | 2 | 2019 | 2359 | 0.080 |
Why?
|
Health Services | 1 | 2013 | 752 | 0.080 |
Why?
|
Referral and Consultation | 1 | 2021 | 3600 | 0.080 |
Why?
|
Helium | 1 | 2008 | 119 | 0.070 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2014 | 3245 | 0.070 |
Why?
|
Williams Syndrome | 1 | 2010 | 194 | 0.070 |
Why?
|
Occupational Diseases | 1 | 2016 | 1490 | 0.070 |
Why?
|
Superoxide Dismutase | 1 | 2010 | 594 | 0.070 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2011 | 411 | 0.070 |
Why?
|
Receptors, Nicotinic | 1 | 2011 | 495 | 0.070 |
Why?
|
Pneumococcal Infections | 1 | 2012 | 501 | 0.070 |
Why?
|
Pulmonary Wedge Pressure | 2 | 2024 | 273 | 0.070 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2014 | 1516 | 0.070 |
Why?
|
Patient Selection | 2 | 2010 | 4244 | 0.070 |
Why?
|
Transplantation Conditioning | 1 | 2014 | 1590 | 0.070 |
Why?
|
Analysis of Variance | 3 | 2011 | 6228 | 0.070 |
Why?
|
Gastroesophageal Reflux | 1 | 2014 | 819 | 0.070 |
Why?
|
Gene Expression Regulation, Bacterial | 1 | 2013 | 1133 | 0.070 |
Why?
|
Inflammasomes | 1 | 2012 | 526 | 0.070 |
Why?
|
Genotype | 7 | 2018 | 12990 | 0.070 |
Why?
|
Critical Illness | 1 | 2019 | 2723 | 0.070 |
Why?
|
Ultrasonography | 1 | 2019 | 5972 | 0.070 |
Why?
|
Elasticity Imaging Techniques | 1 | 2011 | 392 | 0.060 |
Why?
|
Occupational Exposure | 1 | 2016 | 1813 | 0.060 |
Why?
|
Vascular Diseases | 1 | 2014 | 1161 | 0.060 |
Why?
|
Lung Neoplasms | 2 | 2023 | 13380 | 0.060 |
Why?
|
Tobacco Use Disorder | 1 | 2011 | 703 | 0.060 |
Why?
|
Social Class | 1 | 2014 | 2004 | 0.060 |
Why?
|
Risk | 1 | 2017 | 9610 | 0.060 |
Why?
|
Genome, Human | 1 | 2018 | 4425 | 0.060 |
Why?
|
Cytoskeletal Proteins | 1 | 2010 | 1342 | 0.060 |
Why?
|
Pulmonary Medicine | 1 | 2007 | 221 | 0.060 |
Why?
|
Genetic Association Studies | 1 | 2014 | 2735 | 0.060 |
Why?
|
Adiposity | 1 | 2014 | 1878 | 0.060 |
Why?
|
Aging | 2 | 2021 | 8708 | 0.060 |
Why?
|
Anti-Bacterial Agents | 2 | 2014 | 7407 | 0.060 |
Why?
|
Gene Expression | 2 | 2014 | 7581 | 0.060 |
Why?
|
Data Interpretation, Statistical | 2 | 2011 | 2691 | 0.060 |
Why?
|
Air Pollutants | 2 | 2019 | 2896 | 0.060 |
Why?
|
Cluster Analysis | 3 | 2019 | 2707 | 0.060 |
Why?
|
Heart Diseases | 1 | 2017 | 2781 | 0.060 |
Why?
|
DNA Methylation | 1 | 2018 | 4398 | 0.060 |
Why?
|
Incidence | 5 | 2017 | 21353 | 0.060 |
Why?
|
Ozone | 2 | 2019 | 483 | 0.050 |
Why?
|
Manometry | 1 | 2005 | 454 | 0.050 |
Why?
|
Image Enhancement | 2 | 2011 | 2885 | 0.050 |
Why?
|
Age of Onset | 3 | 2015 | 3305 | 0.050 |
Why?
|
Cystic Fibrosis | 1 | 2012 | 1285 | 0.050 |
Why?
|
Self Report | 1 | 2014 | 3724 | 0.050 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2014 | 4369 | 0.050 |
Why?
|
C-Reactive Protein | 1 | 2014 | 3826 | 0.050 |
Why?
|
Models, Statistical | 2 | 2015 | 5079 | 0.050 |
Why?
|
Traction | 1 | 2022 | 110 | 0.050 |
Why?
|
Sex Distribution | 3 | 2014 | 2281 | 0.050 |
Why?
|
Administration, Inhalation | 2 | 2019 | 1157 | 0.050 |
Why?
|
Nerve Tissue Proteins | 2 | 2014 | 4414 | 0.050 |
Why?
|
Area Under Curve | 2 | 2016 | 1638 | 0.050 |
Why?
|
Niacinamide | 1 | 2023 | 413 | 0.050 |
Why?
|
Angiography | 2 | 2019 | 1595 | 0.050 |
Why?
|
Graft vs Host Disease | 1 | 2014 | 3029 | 0.050 |
Why?
|
Apoptosis | 2 | 2014 | 9486 | 0.050 |
Why?
|
Software | 2 | 2020 | 4434 | 0.050 |
Why?
|
Myocardium | 1 | 2014 | 4726 | 0.050 |
Why?
|
Oxygen | 2 | 2023 | 4227 | 0.050 |
Why?
|
Heart | 1 | 2014 | 4404 | 0.050 |
Why?
|
Mothers | 1 | 2011 | 2198 | 0.050 |
Why?
|
TATA Box Binding Protein-Like Proteins | 1 | 2019 | 9 | 0.040 |
Why?
|
Catheterization | 1 | 2005 | 1428 | 0.040 |
Why?
|
beta Karyopherins | 1 | 2019 | 46 | 0.040 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2010 | 2898 | 0.040 |
Why?
|
Magnetic Resonance Imaging, Cine | 2 | 2017 | 1050 | 0.040 |
Why?
|
Quantitative Trait Loci | 2 | 2018 | 2116 | 0.040 |
Why?
|
Artifacts | 2 | 2019 | 1911 | 0.040 |
Why?
|
Growth Differentiation Factor 15 | 1 | 2021 | 198 | 0.040 |
Why?
|
Stroke Volume | 3 | 2022 | 5496 | 0.040 |
Why?
|
Time Factors | 5 | 2019 | 39967 | 0.040 |
Why?
|
APACHE | 1 | 2019 | 267 | 0.040 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2013 | 4580 | 0.040 |
Why?
|
Cytokines | 1 | 2014 | 7396 | 0.040 |
Why?
|
Carrier Proteins | 1 | 2012 | 4936 | 0.040 |
Why?
|
Heterogeneous-Nuclear Ribonucleoprotein Group A-B | 1 | 2018 | 30 | 0.040 |
Why?
|
Treatment Outcome | 7 | 2019 | 64680 | 0.040 |
Why?
|
Vascular Resistance | 1 | 2021 | 930 | 0.040 |
Why?
|
Occupations | 1 | 2020 | 515 | 0.040 |
Why?
|
Heart Failure | 1 | 2022 | 11669 | 0.040 |
Why?
|
Microtubule-Associated Proteins | 2 | 2013 | 1076 | 0.040 |
Why?
|
Cells, Cultured | 4 | 2014 | 18965 | 0.040 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2015 | 3810 | 0.040 |
Why?
|
Activin Receptors, Type I | 1 | 2018 | 134 | 0.040 |
Why?
|
Residence Characteristics | 2 | 2019 | 2093 | 0.040 |
Why?
|
Bronchial Arteries | 1 | 2016 | 21 | 0.040 |
Why?
|
Animals | 11 | 2017 | 168459 | 0.040 |
Why?
|
Treatment Failure | 2 | 2014 | 2645 | 0.030 |
Why?
|
Galactosides | 1 | 1996 | 54 | 0.030 |
Why?
|
Early Diagnosis | 1 | 2021 | 1186 | 0.030 |
Why?
|
Telomere | 1 | 2022 | 943 | 0.030 |
Why?
|
Antibodies, Heterophile | 1 | 1996 | 128 | 0.030 |
Why?
|
Carbon | 1 | 2019 | 666 | 0.030 |
Why?
|
Reference Standards | 1 | 2019 | 1003 | 0.030 |
Why?
|
Pulmonary Surfactant-Associated Protein D | 1 | 2015 | 48 | 0.030 |
Why?
|
Health Status | 3 | 2013 | 4077 | 0.030 |
Why?
|
Matrix Metalloproteinase 7 | 1 | 2015 | 60 | 0.030 |
Why?
|
Cone-Beam Computed Tomography | 1 | 2019 | 474 | 0.030 |
Why?
|
Calibration | 1 | 2017 | 818 | 0.030 |
Why?
|
Mice | 10 | 2017 | 81525 | 0.030 |
Why?
|
Mice, Inbred C57BL | 4 | 2014 | 22169 | 0.030 |
Why?
|
Drug Administration Schedule | 2 | 2014 | 4853 | 0.030 |
Why?
|
Microcirculation | 1 | 2019 | 1273 | 0.030 |
Why?
|
snRNP Core Proteins | 1 | 2014 | 22 | 0.030 |
Why?
|
Mannosidases | 1 | 2014 | 21 | 0.030 |
Why?
|
alpha-Mannosidase | 1 | 2014 | 20 | 0.030 |
Why?
|
Mass Screening | 1 | 2010 | 5428 | 0.030 |
Why?
|
Sex Characteristics | 2 | 2015 | 2639 | 0.030 |
Why?
|
Oligosaccharides | 1 | 1996 | 406 | 0.030 |
Why?
|
Dynamins | 1 | 2014 | 139 | 0.030 |
Why?
|
Air Pollutants, Occupational | 1 | 2016 | 407 | 0.030 |
Why?
|
Influenza A virus | 1 | 1997 | 458 | 0.030 |
Why?
|
Phenylbutyrates | 1 | 2013 | 72 | 0.030 |
Why?
|
Inhalation | 1 | 2013 | 143 | 0.030 |
Why?
|
United States Environmental Protection Agency | 1 | 2013 | 139 | 0.030 |
Why?
|
Thiolester Hydrolases | 1 | 2014 | 90 | 0.030 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2014 | 295 | 0.030 |
Why?
|
RNA Helicases | 1 | 2014 | 144 | 0.030 |
Why?
|
Spain | 1 | 2014 | 487 | 0.030 |
Why?
|
Automation | 1 | 2015 | 586 | 0.030 |
Why?
|
Radiology | 1 | 2007 | 2113 | 0.030 |
Why?
|
N-Acetylglucosaminyltransferases | 1 | 2014 | 167 | 0.030 |
Why?
|
Quinazolinones | 1 | 2014 | 221 | 0.030 |
Why?
|
Qualitative Research | 1 | 2023 | 3023 | 0.030 |
Why?
|
Smoke | 1 | 2014 | 235 | 0.030 |
Why?
|
Asymptomatic Diseases | 1 | 2015 | 588 | 0.030 |
Why?
|
Sirtuin 1 | 1 | 2013 | 246 | 0.030 |
Why?
|
Epigenomics | 1 | 2018 | 943 | 0.030 |
Why?
|
Antilymphocyte Serum | 1 | 2014 | 487 | 0.030 |
Why?
|
Length of Stay | 2 | 2019 | 6425 | 0.020 |
Why?
|
Immunoglobulin G | 2 | 2012 | 4544 | 0.020 |
Why?
|
Microscopy, Electron, Scanning | 1 | 2013 | 945 | 0.020 |
Why?
|
Carbon Monoxide | 1 | 2015 | 547 | 0.020 |
Why?
|
Thigh | 1 | 2013 | 241 | 0.020 |
Why?
|
Mice, Inbred C3H | 1 | 2012 | 915 | 0.020 |
Why?
|
Leukotriene E4 | 1 | 2011 | 75 | 0.020 |
Why?
|
Caspase 1 | 1 | 2012 | 225 | 0.020 |
Why?
|
Chemokines | 1 | 2015 | 960 | 0.020 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2013 | 372 | 0.020 |
Why?
|
Bleomycin | 1 | 2012 | 494 | 0.020 |
Why?
|
Observation | 1 | 2012 | 310 | 0.020 |
Why?
|
Forced Expiratory Flow Rates | 1 | 2010 | 75 | 0.020 |
Why?
|
Principal Component Analysis | 1 | 2013 | 943 | 0.020 |
Why?
|
Serpin E2 | 1 | 2010 | 48 | 0.020 |
Why?
|
Cytosol | 1 | 2013 | 888 | 0.020 |
Why?
|
Macrolides | 1 | 2011 | 205 | 0.020 |
Why?
|
Antigen Presentation | 1 | 1996 | 1251 | 0.020 |
Why?
|
Pulmonary Alveoli | 1 | 2013 | 652 | 0.020 |
Why?
|
Blood Gas Analysis | 1 | 2011 | 379 | 0.020 |
Why?
|
Caspase 3 | 1 | 2012 | 731 | 0.020 |
Why?
|
Necrosis | 1 | 2014 | 1611 | 0.020 |
Why?
|
Elastic Modulus | 1 | 2011 | 211 | 0.020 |
Why?
|
China | 1 | 2016 | 2369 | 0.020 |
Why?
|
Leukotriene B4 | 1 | 2011 | 280 | 0.020 |
Why?
|
Cell Survival | 1 | 2020 | 5791 | 0.020 |
Why?
|
Epoxide Hydrolases | 1 | 2010 | 122 | 0.020 |
Why?
|
Netherlands | 1 | 2014 | 2221 | 0.020 |
Why?
|
Ventricular Function, Left | 1 | 2022 | 3879 | 0.020 |
Why?
|
Health Surveys | 1 | 2019 | 4061 | 0.020 |
Why?
|
Chromosomes, Human, Pair 7 | 1 | 2010 | 310 | 0.020 |
Why?
|
Antibodies, Monoclonal | 2 | 1997 | 9177 | 0.020 |
Why?
|
Antibodies, Viral | 2 | 1997 | 3156 | 0.020 |
Why?
|
Intention to Treat Analysis | 1 | 2010 | 413 | 0.020 |
Why?
|
Organ Specificity | 1 | 2014 | 1967 | 0.020 |
Why?
|
Education | 1 | 2012 | 537 | 0.020 |
Why?
|
Ubiquitination | 1 | 2013 | 1006 | 0.020 |
Why?
|
RNA-Binding Proteins | 1 | 2018 | 1897 | 0.020 |
Why?
|
Internationality | 1 | 2014 | 1001 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2023 | 11121 | 0.020 |
Why?
|
Functional Residual Capacity | 1 | 2008 | 70 | 0.020 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2013 | 774 | 0.020 |
Why?
|
Nasopharynx | 1 | 2011 | 401 | 0.020 |
Why?
|
Elastin | 1 | 2010 | 298 | 0.020 |
Why?
|
Isotopes | 1 | 2008 | 125 | 0.020 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2013 | 1135 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 2019 | 2628 | 0.020 |
Why?
|
Propensity Score | 1 | 2015 | 1913 | 0.020 |
Why?
|
Drug Synergism | 1 | 2012 | 1755 | 0.020 |
Why?
|
Genetic Markers | 1 | 2014 | 2601 | 0.020 |
Why?
|
Alabama | 1 | 2007 | 108 | 0.020 |
Why?
|
Survival Analysis | 1 | 2020 | 10090 | 0.020 |
Why?
|
Protein Kinases | 1 | 2014 | 1608 | 0.020 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2013 | 1320 | 0.020 |
Why?
|
tau Proteins | 1 | 2018 | 2095 | 0.020 |
Why?
|
Cost-Benefit Analysis | 1 | 2020 | 5492 | 0.020 |
Why?
|
Lymphocyte Activation | 2 | 2014 | 5486 | 0.020 |
Why?
|
Autoantibodies | 1 | 2015 | 2116 | 0.020 |
Why?
|
Phagocytosis | 1 | 2012 | 1528 | 0.020 |
Why?
|
Chromosome Mapping | 1 | 2014 | 4615 | 0.020 |
Why?
|
Rest | 1 | 2011 | 918 | 0.020 |
Why?
|
Alleles | 1 | 2017 | 6863 | 0.020 |
Why?
|
Reference Values | 1 | 2013 | 4920 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2014 | 3595 | 0.020 |
Why?
|
Computer Simulation | 1 | 2019 | 6240 | 0.020 |
Why?
|
Protein Processing, Post-Translational | 1 | 2013 | 1974 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2019 | 5294 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2023 | 9280 | 0.020 |
Why?
|
Adrenal Cortex Hormones | 1 | 2014 | 1880 | 0.020 |
Why?
|
Linkage Disequilibrium | 1 | 2010 | 1998 | 0.020 |
Why?
|
Chromosome Deletion | 1 | 2010 | 1386 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2021 | 8002 | 0.020 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2014 | 1897 | 0.010 |
Why?
|
Anti-Inflammatory Agents | 1 | 2014 | 1809 | 0.010 |
Why?
|
Anticoagulants | 1 | 2020 | 4812 | 0.010 |
Why?
|
Neutralization Tests | 2 | 1997 | 728 | 0.010 |
Why?
|
B-Lymphocytes | 1 | 1997 | 4758 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2014 | 6310 | 0.010 |
Why?
|
Drug Resistance, Bacterial | 1 | 2011 | 1048 | 0.010 |
Why?
|
Streptococcus pneumoniae | 1 | 2009 | 730 | 0.010 |
Why?
|
Probability | 1 | 2009 | 2477 | 0.010 |
Why?
|
Electrocardiography | 1 | 2017 | 6377 | 0.010 |
Why?
|
Gene Frequency | 1 | 2010 | 3606 | 0.010 |
Why?
|
Bacterial Infections | 1 | 2011 | 1390 | 0.010 |
Why?
|
Lipids | 1 | 2014 | 3341 | 0.010 |
Why?
|
Immunoglobulin E | 1 | 2009 | 1502 | 0.010 |
Why?
|
Registries | 1 | 2019 | 8224 | 0.010 |
Why?
|
Genomics | 1 | 2018 | 5821 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2013 | 3673 | 0.010 |
Why?
|
Oxidative Stress | 1 | 2012 | 3113 | 0.010 |
Why?
|
Mitochondria | 1 | 2014 | 3624 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 2014 | 4174 | 0.010 |
Why?
|
Mice, SCID | 2 | 1997 | 2626 | 0.010 |
Why?
|
T-Lymphocytes | 2 | 2014 | 10194 | 0.010 |
Why?
|
Recurrence | 1 | 2012 | 8465 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2010 | 6484 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2013 | 14414 | 0.010 |
Why?
|
Adolescent | 2 | 2021 | 88319 | 0.010 |
Why?
|
Muscle, Skeletal | 1 | 2013 | 4948 | 0.010 |
Why?
|
Pneumonia, Viral | 1 | 1995 | 3204 | 0.010 |
Why?
|
Dose-Response Relationship, Immunologic | 1 | 1997 | 364 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2011 | 12341 | 0.010 |
Why?
|
Massachusetts | 1 | 2009 | 8830 | 0.010 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 1 | 1997 | 303 | 0.010 |
Why?
|
Stimulation, Chemical | 1 | 1996 | 306 | 0.010 |
Why?
|
Coronary Artery Disease | 1 | 2016 | 6403 | 0.010 |
Why?
|
Carbohydrate Sequence | 1 | 1996 | 411 | 0.010 |
Why?
|
Vaccines, Inactivated | 1 | 1996 | 179 | 0.010 |
Why?
|
Complement C3 | 1 | 1997 | 435 | 0.010 |
Why?
|
Hemagglutinin Glycoproteins, Influenza Virus | 1 | 1996 | 158 | 0.010 |
Why?
|
Immunization, Passive | 1 | 1997 | 616 | 0.010 |
Why?
|
Injections, Intraperitoneal | 1 | 1995 | 413 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2011 | 7390 | 0.010 |
Why?
|
Immunoglobulin Fab Fragments | 1 | 1995 | 445 | 0.010 |
Why?
|
Antigen-Presenting Cells | 1 | 1996 | 964 | 0.010 |
Why?
|
Immunoglobulin A | 1 | 1995 | 978 | 0.010 |
Why?
|
Viral Vaccines | 1 | 1996 | 596 | 0.010 |
Why?
|
Immunoglobulin M | 1 | 1995 | 1527 | 0.010 |
Why?
|
Epitopes | 1 | 1996 | 2503 | 0.010 |
Why?
|
Blotting, Western | 1 | 1996 | 5035 | 0.000 |
Why?
|
Killer Cells, Natural | 1 | 1997 | 2200 | 0.000 |
Why?
|
Mice, Inbred BALB C | 1 | 1996 | 6216 | 0.000 |
Why?
|
Neoplasms | 1 | 2016 | 22170 | 0.000 |
Why?
|
Child | 1 | 2014 | 80153 | 0.000 |
Why?
|
Mutation | 1 | 2010 | 30052 | 0.000 |
Why?
|
Immunotherapy, Adoptive | 1 | 1995 | 1469 | 0.000 |
Why?
|
Molecular Sequence Data | 1 | 1996 | 17635 | 0.000 |
Why?
|
Disease Models, Animal | 1 | 1997 | 18252 | 0.000 |
Why?
|